Literature DB >> 2452736

Treatment of infantile phytanic acid storage disease: clinical, biochemical and ultrastructural findings in two children treated for 2 years.

E F Robertson1, A Poulos, P Sharp, J Manson, G Wise, A Jaunzems, R Carter.   

Abstract

Two patients with infantile phytanic acid storage disease (infantile Refsum disease), one of whom showed the presence of morphologically normal peroxisomes in a liver biopsy, were treated with a low phytanic acid diet for more than 2 years and the effects of treatment on certain clinical, biochemical and ultrastructural parameters were examined. Both patients showed evidence of either an improvement or stabilisation in their clinical condition. Plasma phytanic acid levels decreased to near normal values in approximately 6 weeks after the introduction of the diet; plasma pipecolic acid also declined markedly but the decrease was not so rapid and its level remained abnormal. C26:C22 fatty acid ratios decreased very slowly and even after 2 years the values remained grossly abnormal. Despite the marked reduction of phytanic acid in the liver, there was an increase in the C26:C22 fatty acid ratios and this appeared to be paralleled by an increase in inclusion bodies. Our data suggest that some patients with the infantile form of Refsum disease may show some clinical benefit from dietary management and this is reflected biochemically by decreases in the plasma levels of phytanic acid and pipecolic acid.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452736     DOI: 10.1007/bf00442210

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  36 in total

1.  Impaired plasmalogen metabolism in infantile Refsum's disease.

Authors:  B T Poll-Thé; H Ogier; J M Saudubray; R B Schutgens; R J Wanders; H van den Bosch; G Schrakamp
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

2.  Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.

Authors:  A Poulos; H Singh; B Paton; P Sharp; N Derwas
Journal:  Clin Genet       Date:  1986-05       Impact factor: 4.438

3.  Phytanic acid in patients with Refsum's syndrome and response to dietary treatment.

Authors:  D Steinberg; C E Mize; J H Herndon; H M Fales; W K Engel; F Q Vroom
Journal:  Arch Intern Med       Date:  1970-01

4.  Refsum's disease, adrenoleucodystrophy, and the Zellweger syndrome.

Authors:  O Stokke; S Skrede; J Ek; I Björkhem
Journal:  Scand J Clin Lab Invest       Date:  1984-09       Impact factor: 1.713

5.  Pipecolic acid: origin, biosynthesis and metabolism in the brain.

Authors:  E Giacobini; Y Nomura; T Schmidt-Glenewinkel
Journal:  Cell Mol Biol Incl Cyto Enzymol       Date:  1980

6.  Lysine metabolism in the rat brain: the pipecolic acid-forming pathway.

Authors:  Y E Chang
Journal:  J Neurochem       Date:  1978-02       Impact factor: 5.372

7.  Dietary effects on serum-phytanic-acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis.

Authors:  L Eldjarn; K Try; O Stokke; A W Munthe-Kaas; S Refsum; D Steinberg; J Avigan; C Mize
Journal:  Lancet       Date:  1966-03-26       Impact factor: 79.321

8.  Identification of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestan-26-oic acid, an intermediate in cholic acid synthesis, in the plasma of patients with infantile Refsum's disease.

Authors:  A Poulos; M J Whiting
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

9.  Peroxisomal defects in neonatal-onset and X-linked adrenoleukodystrophies.

Authors:  S Goldfischer; J Collins; I Rapin; B Coltoff-Schiller; C H Chang; M Nigro; V H Black; N B Javitt; H W Moser; P B Lazarow
Journal:  Science       Date:  1985-01-04       Impact factor: 47.728

10.  Hepatic peroxisomes are deficient in infantile refsum disease: a cytochemical study of 4 cases.

Authors:  F Roels; A Cornelis; B T Poll-The; P Aubourg; H Ogier; J Scotto; J M Saudubray
Journal:  Am J Med Genet       Date:  1986-10
View more
  11 in total

1.  Bone dysplasia associated with phytanic acid accumulation and deficient plasmalogen synthesis: a peroxisomal entity amenable to plasmapheresis.

Authors:  J A Smeitink; F A Beemer; M Espeel; R A Donckerwolcke; C Jakobs; R J Wanders; R B Schutgens; F Roels; M Duran; L Dorland
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 2.  Inherited peroxisomal disorders involving the nervous system.

Authors:  J B Stephenson
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

3.  Pathology of hepatic peroxisomes and mitochondria in patients with peroxisomal disorders.

Authors:  J L Hughes; A Poulos; E Robertson; C W Chow; L J Sheffield; J Christodoulou; R F Carter
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 4.  Peroxisomal disorders: a review.

Authors:  B Fournier; J A Smeitink; L Dorland; R Berger; J M Saudubray; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

5.  Morphometry of peroxisomes and immunolocalization of peroxisomal proteins in the liver of patients with generalised peroxisomal disorders.

Authors:  J L Hughes; D I Crane; E Robertson; A Poulos
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

6.  Autopsy findings in two siblings with infantile Refsum disease.

Authors:  C W Chow; A Poulos; A J Fellenberg; J Christodoulou; D M Danks
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 7.  Liver pathology and immunocytochemistry in congenital peroxisomal diseases: a review.

Authors:  F Roels; M Espeel; D De Craemer
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

8.  Infantile Refsum Disease: Influence of Dietary Treatment on Plasma Phytanic Acid Levels.

Authors:  Maria João Nabais Sá; Júlio C Rocha; Manuela F Almeida; Carla Carmona; Esmeralda Martins; Vasco Miranda; Miguel Coutinho; Rita Ferreira; Sara Pacheco; Francisco Laranjeira; Isaura Ribeiro; Ana Maria Fortuna; Lúcia Lacerda
Journal:  JIMD Rep       Date:  2015-08-25

9.  Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.

Authors:  A Poulos; P Sharp; A J Fellenberg; D W Johnson
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

10.  Formic acid is a product of the alpha-oxidation of fatty acids by human skin fibroblasts: deficiency of formic acid production in peroxisome-deficient fibroblasts.

Authors:  A Poulos; P Sharp; H Singh; D W Johnson; W F Carey; C Easton
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.